METHOD OF INTRAVENOUS INFUSION OF SODIUM HYPOCHLORITE, ACTIVATION OF GLYCOLYSIS, TREATMENT OF BENIGN AND MALIGNANT NEOPLASMS, HIGHER EFFECTIVENESS OF CHEMOTHERAPY OF MALIGNANT NEOPLASMS, TREATMENT OF SECONDARY IMMUNE DEFICIENCY IN GENERALIZED BACTERIAL AND VIRAL INFECTIONS Russian patent published in 2019 - IPC A61K33/14 A61P37/00 A61M1/36 

FIELD: medicine.

SUBSTANCE: invention refers to medicine and concerns intravenous infusion of 0.06 % sodium hypochlorite solution involving glycolysis activation, in therapy and prevention of such conditions as benign and malignant new growths, higher effectiveness of chemotherapy of malignant growths, treatment of secondary immune deficiency in generalized bacterial and viral infections. Invention consists in indirect electrochemical oxidation of blood with 0,06 % sodium hypochlorite solution. Patient's blood for the treatment with sodium hypochlorite is taken from the peripheral vein in 10 or 20 ml syringe with pre-accumulated 0,06 % sodium hypochlorite solution in which it is mixed at ratio of 1:1 and then introduced into a vein through the catheter.

EFFECT: invention provides a safe and effective method of intravenous introduction of 0,06 % sodium hypochlorite solution in the above pathologies.

1 cl, 6 tbl, 5 ex